Доступ предоставлен для: Guest
Critical Reviews™ in Immunology

Выходит 6 номеров в год

ISSN Печать: 1040-8401

ISSN Онлайн: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Cellular Mucins: Targets for Immunotherapy

Том 14, Выпуск 3-4, 1994, pp. 293-309
DOI: 10.1615/CritRevImmunol.v14.i3-4.40
Get accessGet access

Краткое описание

Mucins are attracting great interest as potential targets for immunotherapy in the development of vaccines for cancers expressing Mucinl (MUC1) (e.g., breast, pancreas, ovary, and others) as there is (1) a 10-fold increase in the amount in adenocarcinomas; (2) an alteration in expression where they become ubiquitous, and (3) due to altered glycosylation, new epitopes appear on the cell surface that are absent in normal tissues. These new epitopes can be carbohydrate; others are peptide in nature. The cloning of the cDNAs from mucins, particularly MUC1, has led to rapid advances being made, and it is clear that a highly immunogenic peptide exists within the variable number of tandem repeats (VNTR) found in all mucins. This peptide is immunogenic in mice, giving rise to strong antibody production, and most monoclonal antibodies made to breast cancer, which react with the protein core, react with the peptide APDTR. It is now also clear that humans with breast cancer have, in their draining lymph nodes, precursors of cytotoxic T cells that can be stimulated in vitro to react against breast cancer and indeed against the APDTR or a closely related peptide − shown from antibody-blocking studies. These CTLs are unique in that they are non-MHC restricted. The identification of suitable targets, coupled with the known immunogenicity of both the peptide and neo-carbohydrate epitopes, has led to the development of several different programs to immunize humans against breast cancer using either synthetic carbohydrates or peptides conjugated with adjuvants, and clinical trials are now in progress to evaluate their immunogenicity and anti-cancer effects.

Ключевые слова: mucins, immunotherapy, vaccine, tumor, antigen, peptides
ЦИТИРОВАНО В
  1. Laheru Dan, Jaffee Elizabeth M., Immunotherapy for pancreatic cancer — science driving clinical progress, Nature Reviews Cancer, 5, 6, 2005. Crossref

  2. Melero José A., Molecular Biology of Human Respiratory Syncytial Virus, in Respiratory Syncytial Virus, 14, 2006. Crossref

  3. Sotiriadis John, Shin Soon-Cheon, Yim Daesong, Sieber David, Kim Yoon Berm, Thomsen-Friedenreich (T) antigen expression increases sensitivity of natural killer cell lysis of cancer cells, International Journal of Cancer, 111, 3, 2004. Crossref

  4. Pouniotis Dodie S., Apostolopoulos Vasso, Pietersz Geoffrey A., Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway, Immunology, 117, 3, 2006. Crossref

  5. Barrett John, Childs Richard, The Benefits of an Alloresponse: Graft-Versus-Tumor, Journal of Hematotherapy & Stem Cell Research, 9, 3, 2000. Crossref

  6. Tang Choon-Kit, Apostolopoulos Vasso, Strategies used for MUC1 immunotherapy: preclinical studies, Expert Review of Vaccines, 7, 7, 2008. Crossref

  7. Cho Jung-Ah, Yeo Dong-jun, Son Hye-Youn, Kim Hyun-Wha, Jung Dae-Sun, Ko Jae-Kyun, Koh Jason Soonju, Kim Yong-Nyun, Kim Chul-Woo, Exosomes: A new delivery system for tumor antigens in cancer immunotherapy, International Journal of Cancer, 114, 4, 2005. Crossref

  8. STEINER MITCHELL S., GINGRICH JEFFREY R., GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?, The Journal of Urology, 2000. Crossref

  9. Wilkinson Brendan L., Day Stephanie, Chapman Robert, Perrier Sébastien, Apostolopoulos Vasso, Payne Richard J., Synthesis and Immunological Evaluation of Self-Assembling and Self-Adjuvanting Tricomponent Glycopeptide Cancer-Vaccine Candidates, Chemistry - A European Journal, 18, 51, 2012. Crossref

  10. Lewis A.T., Jones K., Lewis K.E., Jones S., Lewis P.D., Detection of Lewis antigen structural change by FTIR spectroscopy, Carbohydrate Polymers, 92, 2, 2013. Crossref

  11. Bilusic Marijo, Madan Ravi A., Therapeutic Cancer Vaccines, American Journal of Therapeutics, 19, 6, 2012. Crossref

  12. Slovin Susan F, Keding Stacy J, Ragupathi Govind, Carbohydrate vaccines as immunotherapy for cancer, Immunology & Cell Biology, 83, 4, 2005. Crossref

  13. Sheng Kuo-Ching, Pouniotis Dodie S., Wright Mark D., Tang Choon Kit, Lazoura Eliada, Pietersz Geoffrey A., Apostolopoulos Vasso, Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells, Immunology, 118, 3, 2006. Crossref

  14. Barchi Joseph J., Mucin-Type Glycopeptide Structure in Solution: Past, Present, and Future, Biopolymers, 99, 10, 2013. Crossref

  15. LaRue Hélène, Parent-Vaugeois Carmen, Bergeron Alain, Champetier and Serge, Fradet Yves, Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer, International Journal of Cancer, 71, 6, 1997. Crossref

  16. Akashi Hirofumi, Hinoda Yuji, Itoh Fumio, Adachi Masaaki, Endo Takao, Imai Kohzoh, A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4, International Journal of Cancer, 73, 6, 1997. Crossref

  17. Lazoura Eliada, Lodding Jodie, Farrugia William, Day Stephanie, Ramsland Paul A., Apostolopoulos Vasso, Non-canonical anchor motif peptides bound to MHC class I induce cellular responses, Molecular Immunology, 46, 6, 2009. Crossref

  18. Wang Yu-Qian, Zhang Hai-Hong, Liu Chen-Lu, Xia Qiu, Wu Hui, Yu Xiang-Hui, Kong Wei, Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer, Asian Pacific Journal of Cancer Prevention, 13, 11, 2012. Crossref

  19. KIEBER-EMMONS THOMAS, LUO PING, QIU JIANPING, AGADJANYAN MICHAEL, CAREY LISA, HUTCHINS WENDY, WESTERINK M.A. JULIE, STEPLEWSKI ZENON, Peptide Mimicry of Adenocarcinoma-Associated Carbohydrate Antigens, Hybridoma, 16, 1, 1997. Crossref

  20. Schuman J., Campbell A.P., Koganty R.R., Longenecker B.M., Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen, The Journal of Peptide Research, 61, 3, 2008. Crossref

  21. Wierecky J., Mueller M., Brossart P., Dendritic cell-based cancer immunotherapy targeting MUC-1, Cancer Immunology, Immunotherapy, 55, 1, 2006. Crossref

  22. Gul’ko L. B., Pavlova O. V., D’yakov N. A., Okorokova N. A., Ratmanova K. I., Logunova N. N., Bobreneva R. A., Makarov V. A., Yurin V. L., Veiko V. P., Debabov V. G., Construction of a gene of the human tumor-associated antigen VNTR(MUC1) bound to streptavidin, its expression inEscherichia coli, and the study of properties of the hybrid protein, Russian Journal of Bioorganic Chemistry, 26, 6, 2000. Crossref

  23. Wurz Gregory T, Kao Chiao-Jung, Wolf Michael, DeGregorio Michael W, Tecemotide: An antigen-specific cancer immunotherapy, Human Vaccines & Immunotherapeutics, 10, 11, 2014. Crossref

  24. Rachagani Satyanarayana, Torres Maria P., Moniaux Nicolas, Batra Surinder K., Current status of mucins in the diagnosis and therapy of cancer, BioFactors, 35, 6, 2009. Crossref

  25. TROY A.J., HART D.N.J., Review: Dendritic Cells and Cancer: Progress Toward a New Cellular Therapy, Journal of Hematotherapy, 6, 6, 1997. Crossref

  26. Kieber-Emmons Thomas, Peptide mimotopes of carbohydrate antigens, Immunologic Research, 17, 1-2, 1998. Crossref

  27. Zilberberg Jenny, Feinman Rena, Korngold Robert, Strategies for the Identification of T Cell–Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-versus-Tumor Responses after Allogeneic Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation, 21, 6, 2015. Crossref

  28. Lu Yi, Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer, Advanced Drug Delivery Reviews, 61, 7-8, 2009. Crossref

  29. Mittendorf Elizabeth A., Gurney Jennifer M., Storrer Catherine E., Shriver Craig D., Ponniah Sathibalan, Peoples George E., Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer, Surgery, 139, 3, 2006. Crossref

  30. Persson Jonas, Ohlin Mats, Antigens for the selection of pan-variable number of tandem repeats motif-specific human antibodies against Mucin-1, Journal of Immunological Methods, 316, 1-2, 2006. Crossref

  31. Kaminski Joseph M, Summers James B, Ward Matthew B, Huber Mark R, Minev Boris, Immunotherapy and prostate cancer, Cancer Treatment Reviews, 29, 3, 2003. Crossref

  32. Tait Brian D, HLA class I expression on human cancer cells, Human Immunology, 61, 2, 2000. Crossref

  33. STEINER MITCHELL S., GINGRICH JEFFREY R., GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?, Journal of Urology, 164, 4, 2000. Crossref

  34. Martínez Isidoro, Melero José A., Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans, Journal of General Virology , 81, 11, 2000. Crossref

  35. Minev Boris R., Chavez Frances L., Mitchell Malcolm S., Cancer Vaccines, Pharmacology & Therapeutics, 81, 2, 1999. Crossref

  36. Avichezer Dody, Arnon Ruth, Differential reactivities of theArachis hypogaea(peanut) andVicia villosaB4 lectins with human ovarian carcinoma cells, grown either in vitro or in vivo xenograft model, FEBS Letters, 395, 2-3, 1996. Crossref

  37. Slovin Susan F., VACCINES AS TREATMENT STRATEGIES FOR RELAPSED PROSTATE CANCER, Hematology/Oncology Clinics of North America, 15, 3, 2001. Crossref

  38. Zöller Margot, Matzku Siegfried, Cancer Therapy: New Concepts on Active Immunization, Immunobiology, 201, 1, 1999. Crossref

  39. Martínez Isidoro, Melero José A., A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA, Journal of General Virology , 83, 6, 2002. Crossref

  40. Roy René, Baek Myung-Gi, Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T-antigen markers from breast cancer MUC1 glycoprotein, Reviews in Molecular Biotechnology, 90, 3-4, 2002. Crossref

  41. Vaughan Hilary A, Ho Deborah W.M, Karanikas Vaios A, Ong Chin-Swee, Hwang Le Ann, Pearson Julian M, McKenzie Ian F.C, Pietersz Geoffrey A, Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan–human MUC1 conjugates, Vaccine, 17, 20-21, 1999. Crossref

  42. Pietersz Geoffrey A, Li Wenjun, Osinski Carla, Apostolopoulos Vasso, McKenzie Ian F.C, Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1, Vaccine, 18, 19, 2000. Crossref

  43. Vaughan Hilary A, Ho Deborah W.M, Karanikas Vaios, Sandrin Mauro S, McKenzie Ian F.C, Pietersz Geoffrey A, The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan, Vaccine, 18, 28, 2000. Crossref

  44. Lemieux George A, Bertozzi Carolyn R, Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens, Chemistry & Biology, 8, 3, 2001. Crossref

  45. Yuan Shifang, Shi Changhong, Liu Li, Han Wei, MUC1-based recombinant Bacillus Calmette–Guerin vaccines as candidates for breast cancer immunotherapy, Expert Opinion on Biological Therapy, 10, 7, 2010. Crossref

  46. Newman Kimberley D., Sosnowski Deborah L., Kwon Glen S., Samuel John, Delivery of MUC1 Mucin Peptide by Poly(d,l-lactic-co-Glycolic Acid) Microspheres Induces type 1T Helper Immune Responses, Journal of Pharmaceutical Sciences, 87, 11, 1998. Crossref

  47. Kovjazin Riva, Horn Galit, Smorodinsky Nechama I., Shapira Michael Y., Carmon Lior, Dübel Stefan, Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy, PLoS ONE, 9, 1, 2014. Crossref

  48. Shi Lei, Cai Hui, Huang Zhi-Hua, Sun Zhan-Yi, Chen Yong-Xiang, Zhao Yu-Fen, Kunz Horst, Li Yan-Mei, Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern BearingR/S-configured Pam3CysSerLys4, ChemBioChem, 17, 15, 2016. Crossref

  49. Gray H. J., Benigno B., Berek J., Chang J., Mason J., Mileshkin L., Mitchell P., Moradi M., Recio F. O., Michener C. M., Secord A. Alvarez, Tchabo N E., Chan J. K., Young J., Kohrt H., Gargosky S. E., Goh J. C., Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial, Journal for ImmunoTherapy of Cancer, 4, 1, 2016. Crossref

  50. Marcos Nuno T., Cruz Andrea, Silva Filipe, Almeida Raquel, David Leonor, Mandel Ulla, Clausen Henrik, Mensdorff-Pouilly Silvia von, Reis Celso A., Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I Expression in Gastric Carcinoma Cell Lines, Journal of Histochemistry & Cytochemistry, 51, 6, 2003. Crossref

  51. Wurz Gregory T., Kao Chiao-Jung, DeGregorio Michael W., Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential, Therapeutic Advances in Medical Oncology, 8, 1, 2016. Crossref

  52. Carraway Kermit L., Price-Schiavi Shari A., Zhu Xiaoyun, Komatsu Masanobu, 3. Membrane Mucins and Breast Cancer, Cancer Control, 6, 6, 1999. Crossref

  53. KOVJAZIN RIVA, DUBNIK ANNA, HORN GALIT, SMORODINSKY NECHAMA I., HARDAN IZHAR, SHAPIRA MICHAEL YECHIEL, CARMON LIOR, Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis, Experimental and Therapeutic Medicine, 3, 6, 2012. Crossref

  54. Cao Yi, Blohm Dietmar, Ghadimi B. Michael, Stosiek Peter, Xing Pei-Xiang, Karsten Uwe, Mucins (MUC1 and MUC3) of Gastrointestinal and Breast Epithelia Reveal Different and Heterogeneous Tumor-associated Aberrations in Glycosylation, Journal of Histochemistry & Cytochemistry, 45, 11, 1997. Crossref

  55. Dhanisha Suresh Sulekha, Guruvayoorappan Chandrasekharan, Drishya Sudarsanan, Abeesh Prathapan, Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets, Critical Reviews in Oncology/Hematology, 122, 2018. Crossref

  56. Cane Patricia A., Respiratory Syncytial Virus, in The Molecular Epidemiology of Human Viruses, 2002. Crossref

  57. Quaranta M., Coviello M., Daniele A., Abbate I., Durrant L.G., Paradiso A., Schittulli F., MUC3 and MCA Serum Levels and Steroid Receptor Content in Breast Cancer, The International Journal of Biological Markers, 19, 2, 2004. Crossref

  58. Offner Sonja, Hekele Armin, Teichmann Ulrike, Weinberger Susanne, Gross Susanne, Kufer Peter, Itin Christian, Baeuerle Patrick A., Kohleisen Birgit, Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy, Cancer Immunology, Immunotherapy, 54, 5, 2005. Crossref

  59. Brossart Peter, Wirths Stefan, Stuhler Gernot, Reichardt Volker L., Kanz Lothar, Brugger Wolfram, Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells, Blood, 96, 9, 2000. Crossref

  60. Brossart Peter, Wirths Stefan, Stuhler Gernot, Reichardt Volker L., Kanz Lothar, Brugger Wolfram, Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells, Blood, 96, 9, 2000. Crossref

  61. Matzku Siegfried, Z??ller Margot, Specific Immunotherapy of Cancer in Elderly Patients, Drugs & Aging, 18, 9, 2001. Crossref

  62. Laheru Dan, Biedrzycki Barbara, Jaffee Elizabeth M., Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine, in Pancreatic Cancer, 980, 2013. Crossref

  63. Roy René, Recent developments in the rational design of multivalent glycoconjugates, in Glycoscience Synthesis of Substrate Analogs and Mimetics, 187, 1997. Crossref

  64. Janda K. D., New Directions in Immunopharmacotherapy, in The Role of Natural Products in Drug Discovery, 2000. Crossref

  65. Barriga Vanessa, Kuol Nyanbol, Nurgali Kulmira, Apostolopoulos Vasso, The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer, Cancers, 11, 8, 2019. Crossref

  66. Hart Derek N.J., Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response, Blood, 90, 9, 1997. Crossref

  67. Brossart Peter, Heinrich Kathrin S., Stuhler Gernot, Behnke Lars, Reichardt Volker L., Stevanovic Stefan, Muhm Alexandra, Rammensee Hans-Georg, Kanz Lothar, Brugger Wolfram, Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies, Blood, 93, 12, 1999. Crossref

  68. Brossart Peter, Heinrich Kathrin S., Stuhler Gernot, Behnke Lars, Reichardt Volker L., Stevanovic Stefan, Muhm Alexandra, Rammensee Hans-Georg, Kanz Lothar, Brugger Wolfram, Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies, Blood, 93, 12, 1999. Crossref

  69. Fini M. Elizabeth, Jeong Shinwu, Gong Haiyan, Martinez-Carrasco Rafael, Laver Nora M.V., Hijikata Minako, Keicho Naoto, Argüeso Pablo, Membrane-associated mucins of the ocular surface: New genes, new protein functions and new biological roles in human and mouse, Progress in Retinal and Eye Research, 75, 2020. Crossref

  70. Le Dung, Jaffee Elizabeth M., Laheru Dan, Development of Vaccine Therapy for Pancreas Cancer, in Pancreatic Cancer, 2008. Crossref

  71. González-Mariscal Lorenza, Díaz-Coránguez Mónica, Quirós Miguel, Regulation of Tight Junctions for Therapeutic Advantages, in Tight Junctions in Cancer Metastasis, 19, 2013. Crossref

  72. O’Reilly Eileen M., Vaccine Therapy for Pancreatic Cancer, in Pancreatic Cancer, 2002. Crossref

  73. Gao Tong, Cen Qianhong, Lei Han, A review on development of MUC1-based cancer vaccine, Biomedicine & Pharmacotherapy, 132, 2020. Crossref

  74. Bergeron Alain, Champetier Serge, LaRue Hélène, Fradet Yves, MAUB Is a New Mucin Antigen Associated with Bladder Cancer , Journal of Biological Chemistry, 271, 12, 1996. Crossref

  75. Lee Dong-Hee, Choi Seunghyun, Park Yoon, Jin Hyung-seung, Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy, Pharmaceuticals, 14, 10, 2021. Crossref

  76. Laheru Dan, Lutz Eric, Burke James, Biedrzycki Barbara, Solt Sara, Onners Beth, Tartakovsky Irena, Nemunaitis John, Le Dung, Sugar Elizabeth, Hege Kristen, Jaffee Elizabeth, Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation, Clinical Cancer Research, 14, 5, 2008. Crossref

  77. Müller Stefan, Hanisch Franz-Georg, Recombinant MUC1 Probe Authentically Reflects Cell-specific O-Glycosylation Profiles of Endogenous Breast Cancer Mucin, Journal of Biological Chemistry, 277, 29, 2002. Crossref

  78. Fong C L, Mok C-L, Hui K M, Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression, Gene Therapy, 13, 3, 2006. Crossref

  79. Bourgeois C., Bour J. B., Lidholt K., Gauthray C., Pothier P., Heparin-Like Structures on Respiratory Syncytial Virus Are Involved in Its Infectivity In Vitro, Journal of Virology, 72, 9, 1998. Crossref

  80. Gerken Thomas A., Owens Cheryl L., Pasumarthy Murali, Site-specific Core 1 O-Glycosylation Pattern of the Porcine Submaxillary Gland Mucin Tandem Repeat, Journal of Biological Chemistry, 273, 41, 1998. Crossref

  81. Mao Shenlan, Gao Changshou, Lo Chih-Hung L., Wirsching Peter, Wong Chi-Huey, Janda Kim D., Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewis x and Lewis x , Proceedings of the National Academy of Sciences, 96, 12, 1999. Crossref

  82. Medarova Zdravka, Rashkovetsky Leonid, Pantazopoulos Pamela, Moore Anna, Multiparametric Monitoring of Tumor Response to Chemotherapy by Noninvasive Imaging, Cancer Research, 69, 3, 2009. Crossref

  83. Li Zhifeng, Yang Dazhuang, Guo Ting, Lin Mei, Advances in MUC1-Mediated Breast Cancer Immunotherapy, Biomolecules, 12, 7, 2022. Crossref

  84. Ephraim Ramya, Fraser Sarah, Nurgali Kulmira, Apostolopoulos Vasso, Checkpoint Markers and Tumor Microenvironment: What Do We Know?, Cancers, 14, 15, 2022. Crossref

  85. Apostolopoulos Vasso, Stojanovska Lily, Gargosky Sharron E., MUC1 (CD227): a multi-tasked molecule, Cellular and Molecular Life Sciences, 72, 23, 2015. Crossref

  86. Freire Teresa, Landeira Mercedes, Giacomini Cecilia, Festari María Florencia, Pittini Álvaro, Cardozo Viviana, Brosque Alina, Monin Leticia, da Costa Valeria, Faral-Tello Paula, Robello Carlos, Osinaga Eduardo, Trypanosoma cruzi-Derived Molecules Induce Anti-Tumour Protection by Favouring Both Innate and Adaptive Immune Responses, International Journal of Molecular Sciences, 23, 23, 2022. Crossref

Статьи, принятые к публикации

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain